Urolithiasis, characterized by the formation of stones within the urinary system encompassing the kidneys, bladder, and urethra, poses significant health challenges. Kidney stones, a prevalent manifestation of urolithiasis, often manifest with symptoms such as blood in the urine and excruciating pain in the abdominal, flank, or groin regions. The prevalence of kidney stones is noteworthy, affecting approximately 1 in 20 individuals at some point in their lives. Understanding the risk factors associated with kidney disease becomes crucial in assessing susceptibility. Major risk factors include hypertension, diabetes, and a familial history of kidney issues, prevalent among individuals aged 60 and above.
Additional risk factors contribute to the prevalence of urolithiasis among the adult population, creating a complex landscape of susceptibility factors. Lifestyle factors such as smoking, obesity, and cardiovascular diseases escalate the likelihood of developing kidney stones. Notably, statistics from the National Kidney Foundation underline the scale of these risk factors, revealing that over 73 million adults grapple with high blood pressure, while approximately 29 million adults are afflicted with diabetes. These conditions, recognized as major contributors to urolithiasis, underscore the gravity of the situation, indicating a concerning rise in kidney-related issues among the adult population.
The burgeoning cases of urolithiasis, influenced by the prevalence of high blood pressure and diabetes among adults, serve as driving forces behind the growth of the kidney stone market. The correlation between these prevalent health conditions and the increased incidence of kidney stones underscores the urgency for effective interventions and advancements in treatment modalities. As the adult population grapples with these predisposing factors, the demand for innovative solutions for the management and treatment of kidney stones amplifies, propelling the growth trajectory of the kidney stone market.
The convergence of multiple risk factors and their correlation with the rising cases of urolithiasis underscores the imperative for comprehensive approaches to address kidney health. The market's growth isn't merely a reflection of increased diagnoses but also a response to the pressing need for advanced treatments and management strategies in mitigating the prevalence and impact of kidney stones among the adult population. Efforts directed towards preventative measures and innovative interventions remain pivotal in curbing the incidence of kidney stones and improving overall kidney health.
Report Attribute/Metric | Details |
---|---|
Segment Outlook | Type, Treatment Type, Diagnosis and Region |
Kidney Stone Market Size was valued at USD 2.6 billion in 2023. The Kidney Stone Market industry is projected to grow from USD 2.7 Billion in 2024 to USD 4.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period (2024 - 2032).
Growing adoption of minimally invasive stone removal procedures, and advancements in ureteroscopy techniques are the key market drivers boosting the growth of the kidney stone market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The rapid adoption of Minimally Invasive Surgical (MIS) techniques by surgeons has led to a wide variety of applications. In general surgery, minimally invasive methods are being adopted more often than open surgeries. The minimal side effects of MIS procedures compared to open surgery will increase the demand for advanced procedures to manage kidney stones.
The journal Advances in Chronic Kidney Diseases states that minimally invasive treatments have been widely used for three of the most common stone diseases in America extracorporeal, ureteroscopic, and percutaneous renal lithotomy. Procedures that were previously open to the public are now being performed by minimally invasive surgeons.
The kidney stone market segmentation, based on type, includes calcium oxalate stones, uric acid, struvite kidney stones, cystine stones, and calcium phosphate stones. The calcium oxalate stones type segment held the majority share in 2022 with respect to the kidney stone market revenue. This is primarily owing to the high level of oxalate in the urine and lesser intake of water. Also, various risk factors including intake of a diet containing high levels of protein, oxalate, sodium, or sugar may result in calcium oxalate stones formation.
March 2024: Boston Scientific has introduced the LithoVue Empower Retrieval Deployment Device, a new tool that improves the efficiency of stone retrieval during ureteroscopy. This device allows urologists to perform single-handed stone retrieval, reducing procedure time and improving patient outcomes, marking a significant advancement in endoscopic kidney stone management.
February 2024: Olympus Corporation has introduced its next-generation flexible ureteroscope, designed for all kidney stone types. This innovative device offers improved maneuverability, high-definition imaging, and improved visualization, enabling more effective treatment across all stone types. Its ergonomic design and advanced optics enhance procedural efficiency and patient comfort.
The kidney stone market segmentation, based on treatment type, includes medications, extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. The ureteroscopy segment dominated the market in 2022 with respect to the kidney stone market revenue. This is due to the offering to break up stones, take out suspicious-looking tissue, and have an unobstructed urinary tract view.
The kidney stone Market segmentation, based on diagnosis includes ultrasound, intravenous pyelography, CT scan, x-ray, and others. Ultrasound held the largest market share in 2022 with respect to the kidney stone market revenue. This is attributed to the no exposure to radiation, the growing popularity, and the showing of anatomical detail of the kidney in a very less time. It is a safe and painless test that uses sound waves to make images of the kidneys, ureters, and bladder.
April 2024: Siemens Healthcare has introduced the Naeotom Alpha, a photon-counting CT scanner, which offers high-resolution imaging for kidney stone detection. This innovative technology reduces radiation exposure and improves the accuracy of kidney stone diagnosis, including the detection of smaller stones and differentiation between stone types.
March 2024: Boston Scientific has launched the VersaWave Ultrasound System, a portable diagnostic tool for point-of-care kidney stone detection. This high-frequency imaging device, with enhanced Doppler capabilities, is particularly useful in emergency and outpatient settings, providing quick and reliable diagnostic information.
Figure 2 Kidney Stone Market, by Diagnosis, 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America kidney stone held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, and presence of major key companies headquarters in the region are driving the market in the region. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry development.
Further, the major countries studied are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 KIDNEY STONE MARKET SIZE BY REGION 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe kidney stone market accounts for the second-largest market share due to the increasing prevalence of kidney stone disease and the rise in the elderly population across Europe. However, the lack of awareness regarding renal stones hinders market growth. Further, the Germany kidney stone market held the largest market share, and the UK kidney stone market was the fastest-growing market in the European region.
The Asia-Pacific kidney stone market is expected to grow at a significant growth rate during the forecast period. This is due to the rising incidence of kidney stones, the rapidly building healthcare infrastructure, the growing government support, and the rising number of startups in this region. Moreover, China kidney stone market held the largest market share, and the India kidney stone market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2024–2032.
Kidney Stone Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the kidney stone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the kidney stone industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the kidney stone industry to benefit clients and expand the kidney stone market sector is to manufacture locally to reduce operating costs.
Boston Scientific Corporation (US) is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In September 2021, Boston Scientific Corporation acquired a surgical business of Lumenis Ltd. (Israel) a privately held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.
Key Companies in the Kidney Stone Market Includes
Kidney Stone Industry Developments
May 2024: Boston Scientific has introduced the StoneSmart™ System, an innovative solution that combines advanced laser lithotripsy with real-time stone tracking technology. The system uses AI algorithms to optimize laser settings based on stone composition and location, enhancing kidney stone treatment precision and efficiency.
April 2024: Dornier MedTech GmbH has launched SmartLitho Technology, a next-generation shockwave lithotripsy platform, aimed at improving patient comfort and treatment efficacy. The system features adaptive energy settings based on stone size and density, and advanced imaging integration for precise targeting.
March 2024: Olympus Corporation introduced the FlexGuard™ Ureteral Access Sheath in March 2024, designed to improve the passage of endoscopic instruments during kidney stone procedures. The flexible yet durable material reduces ureter trauma, enhances patient safety, and improves procedural efficiency by facilitating easier instrument exchanges.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)